Skip to main content
. 2021 Aug 18;13(8):1286. doi: 10.3390/pharmaceutics13081286

Figure 3.

Figure 3

Initial brain uptake clearance (CLuptake,brain) of [11C]tariquidar, [11C]erlotinib, and [11C]elacridar determined with integration plot analysis in wild-type, Abcb1a/b(−/−), Abcg2(−/−), and Abcb1a/b(−/−)Abcg2(−/−) mice. **** p ≤ 0.0001, one-way ANOVA followed by a Dunnett’s multiple comparison test against the reference group (wild-type).